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Abstract 
 
There is a requirement for the development of oral dosage forms that are adhesive and allow 
extended oesophageal residence time for localised therapies,  or are non-adhesive for ease of 15 
swallowing. This study provides an initial assessment of the in vitro oesophageal retention 
characteristics of several widely utilised pharmaceutical coating materials. To this end, a previously 
described apparatus has been used to measure the force required to pull a coated disc-shaped 
model tablet across a section of excised oesophageal tissue. Of the materials tested, the well-studied 
mucoadhesive polymer sodium alginate was found to be associated with significant oesophageal 20 
adhesion properties that was capable of ‘self-repairing’. Hydroxypropylmethylcellulose exhibited less 
pronounced bioadhesive behaviour and blending this with plasticiser or with low molecular weight 
polymers and surfactants did not significantly affect this. Low molecular weight water soluble 
polymers, were found to behave similarly to the uncoated glass control disc. Polysorbates exhibited 
bioadhesion behaviour that was majorly influenced by the nature of the surfactant. The insoluble 25 
polymer ethylcellulose, and the relatively lipophilic surfactant sorbitan monooleate were seen to 
move more readily than the uncoated disc, suggesting that these may have a role as ‘easy-to-
swallow’ coatings. 
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1. Introduction 
 
Despite the major effort over several decades by pharmaceutical scientists to develop a range of 35 
advanced drug delivery systems, the majority of drugs are still administered in the form of tablets 
and capsules. These are swallowed and need to pass through the oesophagus to reach the stomach 
and small intestine where the drug is absorbed. The adhesion of such solid formulations in the 
oesophagus has been widely implicated in medication-induced injury to this organ.  A high local 
concentration of mucosal irritants (e.g. emepronium bromide, apple-cider vinegar, alendronate 40 
sodium, tetracycline, potassium chloride) within the oesophagus may lead to oesophageal damage 
(Hill et al., 2005; Jaspersen, 2000; Ueda et al., 2011).  In addition, the extended retention of 
therapeutic formulations in the oesophagus may impact on the bioavailability and the 
pharmacokinetics profile of the active. Formulation size, shape and surface characteristics have been 
identified as factors that influence the adhesion of dosage forms in the oesophagus during 45 
swallowing (Channer and Virjee, 1985; Marvola et al., 1982; Perkins et al., 2001).  
 
The  adhesion of solid dosage forms to the oesophagus is often desirable, however, since it may 
provide the means for anchoring formulations designed for the local treatment of gastrooesphageal 
reflux disease (Batchelor et al., 2002) or for pain and inflammation (Mako et al., 2009), or for 50 
delivering diagnostic agents (Collaud et al., 2007).   
 
In a previous study, an in vitro apparatus was developed and validated that allowed adhesive 
interactions to be assessed in terms of the force needed to pull a disc coated with a test material 
over a flattened section of oesophageal mucosa when applying a physiologically relevant shear 55 
stress (Smart et al. 2013). In this study the adhesion/antiadherent properties of a range of 
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pharmaceutical coating materials along with various additives will be evaluated, with regard to their 
likely effect on oesophageal transit. 
 
2. Materials and methods 60 
 
2.1 Materials  
Hydroxypropylmethylcellulose (HPMC), under the trade names Pharmacoat 615 was supplied by 
Harke Group, Muelheim an der Ruhr, Germany;  The Pluronic™ copolymers F127, F98  and F38 were 
supplied by BASF PLC, Cheadle, Cheshire. Poly(ethylene glycol) (PEG) 6,000 MW grade (PEG) and 65 
Paraffin wax (high melting point, ca. 60°C) was purchased from B.D.H Chemicals Ltd, Poole. 
Polyethylene glycol (PEG) (1,450 mw grade and 200 mw grade), Gelatin (type B, from bovine skin), 
sodium alginate (medium viscosity grade from Mactocystis pyrifera)  fluorescein, Type III partially 
purified mucin, from porcine stomach, triacetin and sorbitan monopalmitate (Span 40)  purchased 
from Sigma-Aldrich Chemical Company, Poole, Dorset. Polyvinyl alcohol (PVA) 15,000 mw grade and 70 
ethylcellulose (Ethocel, 10 mPas) were supplied by Fluka Chemicals, Gillingham. LustreClear™ (a 
microcrystalline cellulose/carrageenan/polyethylene oxide based coating), FMC Biopolymer, 
Brussels, Belgium.  
Poly(ethylene oxide), under trade name PolyOx™ (NF grade, WSR N1O mw 100,000) were supplied 
by Dow Chemical Company, Belfast. 75 
 
2.2 Preparation of solutions 
 
Polymer solution concentrations were chosen for their ease of use in the spin-casting process, 
determined in preliminary investigations. Dispersions of HPMC (7% w/w), PEG (15 %w/w), sodium 80 
alginate (1.5% w/w),  gelatin (8% w/w), FI27 (10% w/w), Lustraclear™ (9% w/w)  and PVA (4% w/w) 
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were all prepared by adding the appropriate mass of polymer to rapidly  vortexing (magnetic stirrer) 
de-ionised water. Mixes were prepared in the proportions of HPMC 7.5% / triacetin 1.5%; HPMC 3% 
/ triacetin 1.5%; HPMC 7.5% PEG 200 1.5%; HPMC 3.75%, triacetin 1.5%, F127 3.75%; PVA 4%, F127 
1%. Ethyl cellulose (5% w/w) and sorbitan monopalmitate (7% w/w) were prepared by dissolving in 85 
ethanol and isopropanol respectively. All solutions were stored with stirring overnight before use.  
 
Simulated saliva, as used in our previous studies (Kockisch et al 2004, Smart et al 2013), was 
prepared by dissolving 0.9 % sodium chloride solution in deionised water. To simulate the presence 
of    salivary mucin,  0.5% gastric mucin was added and this stirred using a magnetic stirrer for 1 h at 90 
40c before use. 
 
2.3 Preparation of test discs 
 
Test discs (8mm diameter providing a film surface area of 50.3mm2) were prepared by casting films 95 
from the aqueous polymer solutions using a spin casting technique. The majority of the films were 
spun at a speed of ca. 1000 rpm for 30 seconds, however, the more viscous solutions of HPMC 
blends and sodium alginate required a higher rotation speed of ca. 2000 rpm for 50 seconds. The 
films were then air-dried (at ambient temperature) and weighed; further applications were applied 
until a dry constant weight of between 1.50 - 2.00 mg was achieved. Paraffin wax and PEG (melt) 100 
were melted over a beaker of boiling water. Once molten the glass discs were coated by dipping the 
surface of each into the molten wax using tweezers and were then allowed to set at room 
temperature. The films were stored in a dessicator over silica gel and used within 1 week to avoid 
any discrepancies that may result from    physical ageing. 
 105 
2.4 Experimental 
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The apparatus consisted of the porcine oesophageal mucoadhesion test system described by Smart 
et al. (2013). Effectively the disc coated with the test material on its lower surface and with a 2 g 
weight placed on the upper surface is pulled off a PTFE ‘non-stick’ launch then pulled for 290 s 110 
across a distance of 59.5 mm on a flat section of frozen and thawed pig oesphageal mucosa at a 10° 
angle with a flow of simulated saliva (1 mL min−1) along the tissue (Fig. 1). The force required to 
move the disc was recorded, and only one test was completed on each tissue. To take into account 
tissue variances an identical uncoated roughened glass disc was tested on each tissue before 
adhesion testing with the coated test disc. Each material was tested six times on six different tissues 115 
and the corresponding values of the roughened glass controls are also included for each material.  
Statistical differences were tested using Analysis of Variance with a Multiple comparison - Tukey's 
HSD, p < 0.05. 
 
3. Results 120 
 
This apparatus measures the resistance to movement of the test disc across the oesphageal mucosa. 
Two parameters were evaluated: the Maximum Detachment Force (greatest resistance force to 
movement across the tissue; most often this corresponded with the force associated with resistance 
to initiate movement across the tissue); and, the work done (area under the force-distance curve 125 
over 59.5 mm. To account for differences related to tissue topography, measurements were taken 
first with the uncoated plate followed by a plate coated with the test material on the same tissue 
sample. A ’normalized’ value was calculated by dividing the coated-,by the uncoated plate value, to 
yield the adhesion and detachment ratios.  
 130 
Bioadhesion data for the range of coatings tested is presented on Table 1 and Fig. 2. Of the range of 
coating materials that have been evaluated sodium alginate and HPMC were found to exhibit the 
greatest resistance to movement. Interestingly, one of the least adhesive materials was 
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Lustraclear™, which exhibited an initial detachment force that was significantly higher than that 
seen for the glass plate control.  Coatings of PVA or gelatin exhibited behavior that was very similar 135 
to that of the uncoated glass plate.  The higher molecular weight polyethylene oxide (PolyOx) was 
characterized by a high resistance to movement, while the structurally related lower molecular 
weight  PEGs behaved similarly to the glass plate controls (Table 2, Fig 3). The method of coating, 
from solution or as a melt, had little effect. The mode of deposition (from the melt or from solution) 
of the PEG 1450 coating had little effect on the resistance-to-movement value measured. 140 
 
 Of the three Pluronics tested, only F127 showed a significantly larger adhesion ratio than the 
control (Table 3, Fig 4), while the PVA F127 mix exhibited bioadhesion behaviour that was akin to 
that of the glass plate. F38 was characterized by its very low resistance to the onset of movement, 
as were the water insoluble materials ethylcellulose and sorbitan monooleate, both of displayed 145 
lower resistance to movement than the glass plate (Table 4, Fig. 5).  
 
The mixing of HPMC with triacetin (a plasticizer), a pluronic and PEG did not induce a significant 
effect on the measured biadhesive properties as compared with those determined for HPMC alone 
(Table 5, Fig. 6). 150 
 
4. Discussion 
 
The aim of this study was to use a previously developed test system to evaluate the adhesion of solid 
oral dosage form coatings to oesophageal mucosa using physiologically relevant shear stresses.  In a 155 
typical force-distance plot, there would be an initial increase (from zero) in the force measured as 
tension is applied to the disc. If adhesion is similar to that of controls, the force measured 
corresponds to the frictional force of pulling the disc across the mucosa. Bioadhesion is deemed to 
occur when there is a marked increase in the force measured relative to that for the control. A 
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reduction in the force required to move the coated plate relative to that needed to move the 160 
roughened glass plate identifies the coating material as non –adhesive/lubricating.  
 
In accord with findings from a previous study, sodium alginate is a material that becomes 
bioadhesive on hydration (Mortazavi and Smart 1994, Smart 2014). In addition to exhibiting 
significant bioadhesion, if dislodged this material was seen to self-repair the adhesive joint by re-165 
adhering at the next contact point.  
 
In accord with previous reports and owing to the absence of ionisable structural moieties, HPMC, 
which is employed widely as a tablet coating and also as a bioadhesive in some buccal formulations 
(e.g. Suscard BuccalTM), is confirmed to be a weaker oesophageal bioadhesive than sodium alginate 170 
(Smart 2014). Gelatin, a protein that is the main component of many soft and hard capsules, 
exhibited little evidence of bioadhesive behaviour. Also in accord with previous reports (Mortazavi 
and Smart 1995), PVAs, the hydrophilic non-ionic polymers often used as tablet coatings, were found 
to behave in a similar fashion to the uncoated disc control.  LustreClear™, the microcrystalline 
cellulose/carrageenan/polyethylene oxide based coating that is marketed as a coating with an 175 
‘unparalleled ease of swallowing’, behaved similarly in that it showed some bioadhesive properties 
on application to the tissue (i.e. some force was required to start movement) but the average work 
done to pull the plate across the oesophagus was not significantly different from that obtained for 
the uncoated glass plate. This bioadhesive behaviour may be explained in terms of the 
mucoadhesive component (carrageenan; Mortazavi and Smart 1995) of the coating formulation. 180 
 
Characterised by the dual capability to mask materials for parenteral administration and to prevent 
bacterial biofilm formation (Arciola et al 2012, Teixeira and Gomes 2015), PEGylation may also be 
reasonably assumed to result in materials that hydrate rapidly and form a lubricating ‘slippery 
mucilage’ between the disc and mucosa. Under the testing protocol employed in this study, 185 
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however, the behaviour of PEGs was little different to that of the uncoated disc (Table 2, Fig. 3). It is 
assumed that this behavior is consequent to the PEG coating being rapidly removed in an aqueous 
test environment. Relatively high molecular weight polytheylene oxide coatings, which have been 
used as mucoadhesives (Mortazavi and Smart 1995), required an initial strong detachment force to 
get the disc moving but adhesion ratios were similar to those of the glass-plate control. Blending the 190 
PluronicTM F127 with a low molecular weight water soluble polymer, such as PVA, reduced the 
resistance to initial movement to close to that of the glass plate control. Since PluronicTM surfactants 
consist of two blocks of hydrophilic polyoxethylene flanking a central hydrophobic polyoxypropylene 
block, it may be assumed that in aqueous environments the hydrophilic components orientate 
themselves such that that they become projected outwards from the film to form a hydrated 195 
lubricating coating. F38 (average molecular weight, 4700; HLB, 16.1) exhibited bioadhesion 
behaviour that was insignificantly different to that of the glass plate control. It is possible that it this 
material is rapidly removed from the glass substrate that it coats.  F98 (average molecular weight, 
13000;  HLB, 16) showed some adhesion, notably in the initial detachment force. The less hydrophilic 
F127 (average molecular weight, 12,600;  HLB, 13.8) exhibited significant bioadhesive properties, 200 
indicating its unsuitability for use as an ‘easy to swallow’ tablet coating.  Adhesive failure often arises 
from a cohesive failure of the weakest component of the adhesive joint (Smart 2014) and F127 is 
known to have thermogelation properties on heating to body temperature (Escobar-Chavez et al 
2006).  It is therefore possible that the ability of the polyoxyethylene components to form 
bioadhesive bonds, along with that of the F127 to form stronger gels on exposure to the aqueous 205 
environment and temperature  of this test system, explains its more adhesive nature. 
 
Amongst the materials under evaluation, ethylcellulose, an insoluble tablet coating material, 
exhibited one of the lowest resistance-to-movement values, presumably by providing a smooth 
water-repellent coating to glass disc that glides on interfacial water. Similarly, coatings of sorbitan 210 
monopalmitate, a sparingly water soluble hydrophobic surfactant with a low HLB value (6.7) also 
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showed a very reduced resistant to movement across the mucosa. The hypothesis of the lubricant 
effect of water repelling materials was further tested with paraffin wax (Drake et al., 2002). As 
expected, the maximum detachment force and corresponding work done were directionally lower 
but not significantly different to those obtained with the uncoated glass disc. 215 
 
The incorporation of a plasticizer (e.g. triacetin; commonly used in pharmaceutical coatings) in 
HPMC (Table 5, Fig. 6) or the mixing of HPMC with a low molecular weight PEG or with a pluronic 
surfactant did not alter the bioadhesive properties of corresponding coatings. 
 220 
This work evaluated a range of coating materials for their capability to influence the residence time 
of a solid dosage form in the oesophagus. A lipophilic surfactant and a water-insoluble polymer have 
been shown to promote rapid transit, suggesting their suitability as candidate coating materials for 
easy-to-swallow solid oral formulations. By contrast, known mucoadhesive materials used as 
coatings slowed the transit of a coated modelled tablet.  The work identifies promising oesophageal 225 
coating materials, especially for easy-to-swallow solid dosage forms.  
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Table 1. Average work done (WD) and maximum detachment forces (MDF) for polymer coatings 
relative to roughened glass controls, evaluated in the in vitro test system. 
 
 275 
Material  Film weight / mg (s.d.) WD /μJ (n = 6, s.d.)  MDF / mN (n = 6, s.d.)  
Sodium alginate  1.96 (0.09)  4154.03  (1379.01) 263.42 (111.39) 
Glass control   666.35 (72.71) 13.72 (1 .11) 
HPMC  1.73 (0.18)  1209.28 (339.70) 95.14 (43.68) 
Glass control   665.01 (118.83) 14.52 (2.52) 
LustreClear  1.74 (0.04)  900.91 (44.45) 71.52 (32.46) 
Glass control   801.25 (127.64) 17.31 (2.26) 
PVA  1.92 (0.10)  625.23 (57.00) 29.11 (8.36) 
Glass control   628.94 (73.54) 13.44 (2.99) 
Gelatin 1.89 (0.20)  575.25 (76.02) 19.83 (7.61) 
Glass control   605.51 (70.79) 12.58 (2.03) 
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Table 2. Average work done (WD) and maximum detachment forces (MDF) for polyoxyethylene 
polymer coatings relative to roughened glass controls evaluated in the in vitro test system.  280 
Material  Film weight / mg (s.d.) WD /μJ (n = 6, s.d.) MDF / mN (n = 6, s.d.) 
PolyOx  1.98 (0.15)  744.51 (80.71) 48.98 (16.34) 
Glass control   705.08 (47.05) 14.77 (0.70) 
PEG 1,450 (solution)  1.90 (0.70)  653.96 (91.05) 14.37 (2.47) 
Glass control   586.04 (71.61) 13.00 (1.57) 
PEG 1,450 (Melt)  3.26 (0.15)  611.23 (74.51) 16.66 (1.80) 
Glass control   559.70 (47.38) 12.35 (2.38) 
PEG 6,000  1.83 (0.16)  591.50 (98.85) 12.70 (1.84) 
Glass control   585.49 (54.69) 12.86 (2.05) 
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Table 3. Average work done (WD) and maximum detachment forces (MDF) for Pluronic""" 
copolymers coatings relative to roughened glass controls evaluated in the in vitro test system.  
Material  Film weight / mg (s.d.) WD /μJ (n = 6, s.d.) MDF / mN (n = 6, s.d.) 
F127 1.82 (0.17)  1121.57 (361.05) 81.85 (37.57) 
Glass control   526.20 (59.86) 11.56 (1.92) 
F98 1.88 (0.18)  782.82 (83.72) 48.67 (14.67) 
Glass control   480.26 (59.94) 9.98 (1.11) 
F38  1.81 (0.18)  572.16 (65.89) 13.19 (2.34) 
Glass control   575.21 (85.14) 12.49 (2.33) 
PVA/F127  1.67 (0.20)  505.29 (43.09) 20.36 (5.21) 
Glass control   513.65 (92.52) 10.78 (1.84) 
 285 
 
Table 4. Average work done (WD) and maximum detachment force (MDF) values for 
Hydrophobic coatings and roughened glass controls evaluated in the in vitro test system.  
Material  Film weight / mg (s.d.) WD /μJ (n = 6, s.d.) MDF / mN (n = 6, s.d.) 
Ethylcellulose  1.76 (0.23)  438.52 (22.72) 8.59 (0.59) 
Glass control   734.46 (59.01) 16.01 (2.03) 
Paraffin wax  3.5 (0.20)  416.44 (54.84) 8.61 (1.35) 
Glass control   532.32 (57.52) 10.60 (1.42) 
Sorbitan 
monopalmitate  
1.98 (0.20)  339.01 (29.82) 7.01 (0.85) 
Glass control   608.10 (89.89) 13.07 (2.05) 
 
 290 
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Table 5. Average work done (WD) and maximum detachment force (MDF) values for polymer blend 
coatings relative to roughened glass controls evaluated in the in vitro test system. 
Material  Film weight / mg (s.d.) WD /μJ (n = 6, s.d.) MDF / mN (n = 6, s.d.) 
HPMC/triacetin (2:1)  1.93 (0.32)  1095.91 (338.49) 51.46 (22.70) 
Glass control   570.00 (43.67) 12.09 (1.32) 
HPMC/triacetin (5:1)  1.86 (0.17)  1244.75 (275.32) 108.49 (35.00) 
Glass control   603.48 (75.18) 13.21 (3.18) 
HPMC/PEG 200 (5:1) 1.72 (0.27)  1196.05 (169.03) 74.05 (18.72) 
Glass control   688.51 (37.50) 15.71 (0.90) 
HPMC/triacetin/F127 
(2.5:1.0:2.5)  
1.93 (0.14)  1297.67 (281.96) 77.64 (29.53) 
Glass control   625.60 (109.85) 13.71 (2.35) 
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Fig. 1. Schematic diagram of the in vitro oesophageal adhesion model  295 
Fig. 2. Adhesion and detachment ratios calculated for various coating materials  evaluated in the in 
vitro test system (n = 6, s.d. bars).  
Fig. 3.Adhesion and detachment rations for the hydrophilic polymers (n=6, s.d. bars) 
Fig. 4. Adhesion and detachment rations for the pluronic polymers (n=6, s.d. bars) 
Fig. 5. Adhesion and detachment rations for the hydrophobic/insoluble polymers (n=6, s.d. bars) 300 
Fig. 6. Adhesion and detachment ratios calculated for polymer blends relative to HPMC (n = 6, s.d. 
bars).  
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